ATBF1 Inhibits Estrogen Receptor (ER) Function by Selectively Competing with AIB1 for Binding to the ER in ER-positive Breast Cancer Cells

AIB1 is required for the acquisition of epithelial growth factor receptor-mediated tamoxifen resistance in breast cancer cells

(2009) Wenhui Zhao et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

The role and regulation of the nuclear receptor co-activator AIB1 in breast cancer

(2009) Tyler Lahusen et al.   BREAST CANCER RESEARCH AND TREATMENT

Loss of heterozygosity at the ATBF1-A locus located in the 16q22 minimal region in breast cancer

(2008) Kazuharu Kai et al.   BMC CANCER

ATBF1 and NQO1 as candidate targets for allelic loss at chromosome arm 16q in breast cancer: Absence of somatic ATBF1 mutations and no role for the C609T NQO1 polymorphism

(2008) Anne-Marie Cleton-Jansen et al.   BMC CANCER

The Nuclear Receptor Coactivator Amplified in Breast Cancer-1 Is Required for Neu (ErbB2/HER2) Activation, Signaling, and Mammary Tumorigenesis in Mice

(2008) M. P. Fereshteh et al.   CANCER RESEARCH

Amplified in breast cancer 1 expression in breast cancer

(2008) M A Thorat et al.   HISTOPATHOLOGY

Pro-proliferative Factor KLF5 Becomes Anti-proliferative in Epithelial Homeostasis upon Signaling-mediated Modification

(2008) Peng Guo et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Role of AIB1 for Tamoxifen Resistance in Estrogen Receptor-Positive Breast Cancer Cells

(2008) Qingbo Su et al.   ONCOLOGY